RESCUE

Serial Number 88930140
606

Registration Progress

Application Filed
May 22, 2020
Under Examination
Oct 19, 2021
Approved for Publication
Apr 27, 2021
Published for Opposition
Apr 27, 2021
Registered

Basic Information

Serial Number
88930140
Filing Date
May 22, 2020
Published for Opposition
April 27, 2021
Abandonment Date
May 20, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 20, 2024
Classes
005

Rights Holder

EIRGEN PHARMA LTD.

99
Address
WESTSIDE BUSINESS PARK
OLD KILMEADEN ROAD
WATERFORD X91YV67
IE

Ownership History

OPKO IRELAND GLOBAL HOLDINGS, LTD.

Original Applicant
99
GRAND CAYMAN KY

OPKO IRELAND GLOBAL HOLDINGS, LTD.

Owner at Publication
99
GRAND CAYMAN KY

EIRGEN PHARMA LTD.

New Owner After Publication #1
99
WATERFORD IE

Legal Representation

Attorney
Richard M. LaBarge

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description
May 20, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 20, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 18, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 16, 2023 EX4G S SOU EXTENSION 4 GRANTED
Oct 16, 2023 EXT4 S SOU EXTENSION 4 FILED
Oct 16, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2023 EX3G S SOU EXTENSION 3 GRANTED
Apr 18, 2023 EXT3 S SOU EXTENSION 3 FILED
Apr 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 19, 2022 EX2G S SOU EXTENSION 2 GRANTED
Oct 19, 2022 EXT2 S SOU EXTENSION 2 FILED
Oct 19, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 26, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2022 EX1G S SOU EXTENSION 1 GRANTED
Apr 25, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 19, 2022 EXT1 S SOU EXTENSION 1 FILED
Apr 19, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 19, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 5, 2021 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 12, 2021 CHPB I CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Aug 12, 2021 APET A ASSIGNED TO PETITION STAFF
Aug 5, 2021 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 21, 2021 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 25, 2021 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 27, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2021 PUBO A PUBLISHED FOR OPPOSITION
Apr 7, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 31, 2020 GNRT F NON-FINAL ACTION E-MAILED
Aug 31, 2020 CNRT R NON-FINAL ACTION WRITTEN
Aug 24, 2020 DOCK D ASSIGNED TO EXAMINER
Jun 9, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
prescription pharmaceutical products, namely, calcifediol for treating symptoms from infection with the SARS-CoV-2 virus (COVID-19)

Classification

International Classes
005